Oncological repercussions of polycystic ovary syndrome

Gynecological Endocrinology

Volumn 26, Issue 10, 2010, Pages 708-711

  De França Neto, Antônio H ^a   Rogatto, Silvia ^b   Do Amorim, Melania M R ^c   Tamanaha, Sonia ^d   Aoki, Tsutomu ^d   Aldrighi, José M ^d  

^a Nova Esperança School of Medicine João Pessoa   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

^d Saõ Paulo Santa Casa Hospital   (Brazil)

Author keywords

breast cancer; cancer; endometrial cancer; insulin resistance; obesity; ovarian cancer; PCOS

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER RISK; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOCRINE DISEASE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; GYNECOLOGIC CANCER; HUMAN; INSULIN RESISTANCE; OBESITY; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

ADENOCARCINOMA; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OVARIAN NEOPLASMS; POLYCYSTIC OVARY SYNDROME;

EID: 77956527175     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.490607     Document Type: Review

References (42)

1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-191.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
3. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1988;1:870-872.
4. Futterweit W, Mechanick JI. Polycystic ovarian disease: etiology, diagnosis and treatment. Compr Ther 1988;14:12-20.
5. Carneiro MM, Camargos AF, Aldrighi JM. Síndrome dos ovários policísticos. In: Aldrighi JM, editor. Endocrinologia ginecológica-aspectos contemporâneos, São Paulo: Atheneu; 2006. pp 115-123.
6. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M. The genetic basis of polycystic ovary syndrome. Hum Reprod 1997;12:2641-2648.
7. Dasgupta S, Reddy BM. Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 2008;54:115-125.
8. Unluturk U, Harmanci A, Kocaefe C, Yildiz BO. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-g. PPAR Res 2007;2007:49109.
9. Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998; 95:14956-14960.
10. Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 2002;78:569-576.
11. Franks S, McCarthy M. Genetics of ovarian disorders: polycystic ovary syndrome. Rev Endocr Metab Disord 2004;5:69-76.
12. Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001;7:522-525.
13. Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, Menon PA, Leonard AJ, Hardiman P. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21:924-929.
14. Spritzer PM, Morsch DM, Wiltgen D. [Polycystic ovary syndrome associated neoplasms.] Arq Bras Endocrinol Meta-bol 2005;49:805-810.
15. Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med 2008;26:62-71.
16. Key TJ, Pike MC. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-212.
17. Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 1999;28:247-263.
18. Giudice LC, Dsupin BA, Jin IH, Vu TH, Hoffman AR. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J Clin Endocrinol Metab 1993;76:1115-1122.
19. Rutanen EM. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery. Hum Reprod 2000;15 (Suppl 3):173-181.
20. Zhou J, Dsupin BA, Giudice LC, Bondy CA. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1994;79: 1723-1734.
21. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
22. Diamanti-Kandarakis E, Baillargeon JP, Iuorno MJ, Jakubow-icz DJ, Nestler JE. A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J Clin Endocrinol Metab 2003;88:1927-1932.
23. World Health Organization. WHOSIS (WHO Statistical Information System). Available from: http://www.who.int/healthinfo/statistics/ bodgbddeathdalyestimates.xls
24. National Cancer Institute. Available from: http://www.cancer. gov/cancertopics/types/endometrial
25. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância de Câncer. Estimativas 2008: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2007.
26. Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 2005;105:575-580.
27. Speert H. Carcinoma of the endometrium in young women. Surg Gynaecol Obstet 1949;88:332-336.
28. Dockerty MB, Jackson RL. The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1957;73:161-173.
29. Chamlian DL, Taylor HB. Endometrial hyperplasia in young women. Obstet Gynecol 1970;36:659-666.
30. Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, Bahamondes L. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. Aust N Z J Obstet Gynaecol 2008;48:207-213.
31. Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, Vouxinou A, Georgopoulos NA, Kourounis G. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol 2006;127:218-221.
32. Gouveia DA, Bahamondes L, Aldrighi JM, Tamanaha S, Ribeiro AL, Aoki T. [Prevalence of endometrial injury in asymptomatic obese women.] Rev Assoc Med Bras 2007;53:3 44-348.
33. Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database Syst Rev 2007;(1): CD005552.
34. Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;79:494-499.
35. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991;134:818-824.
36. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61: 403-417.
37. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long term follow-up. J Clin Epidemiol 1998;51:581-586.
38. Heintz AP, Hacker NF, Lagasse LD. Epidemiology and etiology of ovarian cancer: a review. Obstet Gynecol 1985;66: 127-135.
39. Silva-Filho AL, Cândido EB, Noviello MB, Santos-Filho AS, Traiman P, Triginelli SA, Cunha-Melo JR. [Nongynecologic surgery in patients with ovarian cancer.]. Rev Bras Ginecol Obstet 2004;26:411-416.
40. Meirow D, Schenker JG. The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod Update 1996;2:63-75.
41. Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88:554-559.
42. Olsen CM, Green AC, Nagle CM, Jordan SJ, Whiteman DC, Bain CJ, Webb PM; Australian cancer study Group (ovarian cancer) and the Australian ovarian cancer study group. Epithelial ovarian cancer: testing the 'androgens hypothesis'. Endocr Relat Cancer 2008;15:1061-1068.